Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 29, 2024
Dec. 30, 2023
Current Assets    
Cash and cash equivalents $ 110.1 $ 171.7
Accounts receivable, less allowance for credit losses of $4.0 and $3.6, at June 29, 2024 and December 30, 2023, respectively 178.8 174.1
Contract assets 32.7 49.7
Inventories 50.8 48.4
Prepaid expenses 8.8 8.4
Other current assets 24.9 10.8
Total current assets 406.1 463.1
Property, plant and equipment, net 57.6 52.4
Right-of-use assets, net 52.5 50.9
Intangible assets, net 401.2 375.3
Goodwill 384.3 368.6
Deferred tax asset, net 31.1 36.8
Other assets 2.6 2.9
Total assets 1,335.4 1,350.0
Current Liabilities    
Accounts payable 57.8 59.8
Contract liabilities 25.5 26.7
Current maturities of long-term debt 7.3 7.3
Accrued expenses and other current liabilities 53.5 80.3
Total current liabilities 144.1 174.1
Long-term debt, net 585.8 607.7
Deferred tax liability, net 1.7 1.7
Other long-term liabilities 47.5 46.9
Total liabilities 779.1 830.4
STOCKHOLDERS’ EQUITY    
Common stock, 825,000,000 shares authorized, $0.0001 par value, 147,194,938 and 146,861,489 shares issued at June 29, 2024 and December 30, 2023, respectively 0.0 0.0
Treasury stock, at cost, 1,886,228 and 34,297 shares as of June 29, 2024 and December 30, 2023, respectively (26.9) (0.4)
Additional paid-in capital 294.3 289.0
Accumulated other comprehensive loss (3.3) (2.9)
Retained earnings 292.2 233.9
Total stockholders’ equity 556.3 519.6
Total liabilities and stockholders’ equity $ 1,335.4 $ 1,350.0